Renal infarction secondary to Aspergillus spp. embolism following COVID-19

Lancet Infect Dis. 2024 Apr;24(4):e266-e267. doi: 10.1016/S1473-3099(23)00780-6.
No abstract available

MeSH terms

  • Antifungal Agents / therapeutic use
  • Aspergillus
  • COVID-19* / complications
  • Embolism*
  • Humans
  • Infarction

Substances

  • Antifungal Agents